Completed PHASE2 INTERVENTIONAL 2-arm NCT00350883

Cognitive Therapy for Negative Symptoms and Functioning

Sponsor: National Alliance for Research on Schizophrenia and Depression

Conditions Schizoaffective Disorder Schizophrenia

Interventions Cognitive Therapy Treatment as Usual

Updated 5 times since 2017 Last updated: May 2, 2012 Started: Jul 31, 2006 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Schizoaffective Disorder and Schizophrenia and is currently completed. National Alliance for Research on Schizophrenia and Depression leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Alliance for Research on Schizophrenia and Depression
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States